first patients enroll in us stem cell trials on blindness
Last Updated : GMT 06:49:16
Arab Today, arab today
Arab Today, arab today
Last Updated : GMT 06:49:16
Arab Today, arab today

First patients enroll in US stem cell trials on blindness

Arab Today, arab today

Arab Today, arab today First patients enroll in US stem cell trials on blindness

Washington - AFP

The first clinical trials that examine the use of stem cells to treat two forms of blindness are ready to begin now that patients have been enrolled, a US company announced on Thursday. A total of 24 patients have entered two separate trials at an eye institute in California, said representatives from the Massachusetts-based Advanced Cell Technology. ACT was cleared by the US Food and Drug Administration several months ago to begin clinical trials of human embryonic stem cells to treat a form of juvenile blindness known as Stargardt's disease and dry age-related macular degeneration. Now that patients have been enrolled, the trials will begin "in the very near future," a company spokeswoman said. The trials aim to check the safety of the treatment before moving on to see whether the therapy can help stop vision loss. "These trials mark a significant step toward addressing what is one of the largest unmet medical needs of our time, treatments for otherwise untreatable and common forms of legal blindness," said lead investigator Steven Schwartz at University of California Los Angeles Jules Stein Eye Institute. Dry age-related macular degeneration is the most common form of irreversible vision loss in people over age 55. There is currently no cure for the disease, which affects around 10-15 million Americans and another 10 million people in Europe, the company said. Stargardt's disease causes blindness by destroying the pigmented layer of the retina, called the retinal pigment epithelium (RPE). After that follows degradation of photoreceptors, which are cells in the retina that detect light. Patients often experience blurry vision, difficulty seeing in low-light and eventually most lose their ability to see at all. The disease can be inherited by a child when two parents carry the gene mutation that causes it. The treatment process being tested by ACT worked in animals by creating an abundance of new RPE cells, which are the first cells to die off in Stargardt's and other forms of macular degeneration. Tests on rats have shown 100 percent improvement in visual performance and "near-normal function" was also achieved in mice, both without negative side effects, ACT has said. Embryonic stem cell research has been a controversial field ever since the first such stem cells were isolated more than 12 years ago. Scientists say the cells offer great promise in treating Parkinson's disease, diabetes and a variety of other illnesses. Critics frequently oppose the research on religious grounds because it involves the destruction of human embryos.

arabstoday
arabstoday

Name *

E-mail *

Comment Title*

Comment *

: Characters Left

Mandatory *

Terms of use

Publishing Terms: Not to offend the author, or to persons or sanctities or attacking religions or divine self. And stay away from sectarian and racial incitement and insults.

I agree with the Terms of Use

Security Code*

first patients enroll in us stem cell trials on blindness first patients enroll in us stem cell trials on blindness

 



Name *

E-mail *

Comment Title*

Comment *

: Characters Left

Mandatory *

Terms of use

Publishing Terms: Not to offend the author, or to persons or sanctities or attacking religions or divine self. And stay away from sectarian and racial incitement and insults.

I agree with the Terms of Use

Security Code*

first patients enroll in us stem cell trials on blindness first patients enroll in us stem cell trials on blindness

 



GMT 09:37 2012 Saturday ,28 April

Asamoah Gyan celebrates UAE title

GMT 06:57 2017 Tuesday ,12 December

Latest Grateful Dead resurrection -- a duo

GMT 14:03 2017 Friday ,10 February

3 Chinese miners killed in accident in Albania

GMT 10:06 2018 Sunday ,14 January

Qanso, Kijian tackle recent developments

GMT 18:58 2017 Saturday ,04 March

Gold prices continue to fall

GMT 12:49 2017 Thursday ,24 August

Fadl Shaker could be arrested soon

GMT 02:06 2017 Monday ,30 October

May22/Jun21

GMT 22:28 2017 Thursday ,24 August

February20th-March20th

GMT 08:07 2017 Saturday ,18 November

BBA President visits BHA

GMT 02:27 2017 Saturday ,28 October

September24th-October23rd

GMT 14:20 2017 Saturday ,26 August

Former VW engineer gets 40 months
Arab Today, arab today
 
 Arab Today Facebook,arab today facebook  Arab Today Twitter,arab today twitter Arab Today Rss,arab today rss  Arab Today Youtube,arab today youtube  Arab Today Youtube,arab today youtube

Maintained and developed by Arabs Today Group SAL.
All rights reserved to Arab Today Media Group 2025 ©

Maintained and developed by Arabs Today Group SAL.
All rights reserved to Arab Today Media Group 2025 ©

arabstoday arabstoday arabstoday arabstoday
arabstoday arabstoday arabstoday
arabstoday
بناية النخيل - رأس النبع _ خلف السفارة الفرنسية _بيروت - لبنان
arabstoday, Arabstoday, Arabstoday